Innovation at Boehringer Ingelheim is founded in the Company’s desire to discover and develop new medications of high therapeutic value. Partnerships between our own team of highly experienced scientists and our growing global network of academic and industry partners, provide a rich source of fuel for Boehringer Ingelheim’s research and development engine. With an active investment program in external partnerships, we are seeking opportunities across the entire drug discovery and development value chain, so together we can improve the health of people around the world.
With more than 50% of our early-mid stage pipeline anchored in external collaborations, we are committed to pursuing, with our partners, the healthcare solutions of the future.
If you share our goal of researching and developing new medications of high therapeutic value, to improve the health of people around the world, then find out more about partnering with us on these pages and how we can work together for better health.